chronic obstructive pulmonary disease
Conditions
Interventions
The treatment group:Oral dragon cough and asthma capsule
The control group:Take a placebo
Sponsors
The First Affiliated Hospital Of Guangzhou Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) consent to participate in this clinical trial and sign informed consent; (2) aged from 40 to 80 years old, male or female, good compliance, outpatient or inpatient; (3) diagnosed with chronic obstructive pulmonary disease (mild and moderate); (4) those did not use expectorant or antitussive drugs within the week before entering the group.
Exclusion criteria
Exclusion criteria: (1) those who do not meet the inclusion criteria; (2) those have chest trauma, lung and pleural neoplasms, bronchial asthma, bronchiectasis, pneumothorax, or other respiratory diseases, as well as drugs and chemical poisons; (3) those have cancer, nephritis, blood diseases and mental disorders; (4) unable to adhere to the treatment and cannot complete the observation period of treatment due to the severe adverse reactions; (5) allergic to this drugs and the variety of this drug; (6) those have serious heart disease or kidney, liver and kidney function abnormalities (ALT and AST = 1.5 times the upper limit of normal, Cr >the upper limit of normal); (7) pregnant women, lactating women or recent fertility planners; (8) Those who are alcoholism or have other habits are not appropriate to serves as drug testing observers; (9) participated in other clinical trials 3 months before; (10) patients that are not meet the requirements of this clinical trial given by researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood routine;Urine routine;Coagulation;Liver and kidney function;Twelve-lead electrocardiogram;Urine pregnancy test; | — |
Countries
China
Contacts
Public ContactWang Peng
The First Affiliated Hospital Of Guangzhou Medical University
Outcome results
None listed